| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10484624 | Value in Health | 2014 | 10 Pages |
Abstract
Using different algorithms to convert the HAQ score to utility affects the cost-effectiveness of second-line biologics for the treatment of RA. Using different algorithms in economic modeling for RA could lead health technology assessment bodies to make different reimbursement decisions.
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
Becky MSc, Sarah MPhys,